Sandoz launches biosimilar Pyzchiva® (ustekinumab-ttwe) in the US, offering new treatment for around 12 million patients[1-4]
Notified -
Globe Newswire24-02-2025, 13:00
Schneider Electric champions greater adoption of sustainable technology ahead of the World Economic Forum Annual Meeting in Davos 15-01-2025, 14:02
